BRAINTRAIN

Taking imaging into the therapeutic domain: Self-regulation of brain systems for mental disorders

Coordinatore	more  Organization address address: Newport Road 30-36 city: CARDIFF postcode: CF24 ODE contact info Titolo: Dr. Nome: Keith Cognome: Sexton Email: send email Telefono: +44 2 920879288 Fax: +44 2 920874189
Nazionalità Coordinatore	Non specificata
Totale costo	7˙783˙520 €
EC contributo	0 €
Programma	FP7-HEALTH Specific Programme "Cooperation": Health
Anno di inizio	2013
Periodo (anno-mese-giorno)	2013-11-01   -   2017-10-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	CARDIFF UNIVERSITY  Organization address address: Newport Road 30-36 city: CARDIFF postcode: CF24 ODE contact info Titolo: Dr. Nome: Keith Cognome: Sexton Email: send email Telefono: +44 2 920879288 Fax: +44 2 920874189	UK (CARDIFF)	coordinator	1˙052˙241.00
2	BRAIN INNOVATION BV  Organization address address: OXFORDLAAN 55 city: MAASTRICHT postcode: 6229 EV contact info Titolo: Ms. Nome: Claudia Cognome: Goebel Email: send email Telefono: +31 43 2100120	NL (MAASTRICHT)	participant	1˙752˙000.00
3	TEL AVIV UNIVERSITY  Organization address address: RAMAT AVIV city: TEL AVIV postcode: 69978 contact info Titolo: Ms. Nome: Lea Cognome: Pais Email: send email Telefono: 97236408774 Fax: 97236409697	IL (TEL AVIV)	participant	711˙000.00
4	UNIVERSIDADE DE COIMBRA  Organization address address: PACO DAS ESCOLAS city: COIMBRA postcode: 3001 451 contact info Titolo: Ms. Nome: Helena Cognome: Azevedo Mendes Email: send email Telefono: +351 239 700 625	PT (COIMBRA)	participant	638˙000.00
5	UNIVERSITY COLLEGE LONDON  Organization address address: GOWER STREET city: LONDON postcode: WC1E 6BT contact info Titolo: Ms. Nome: Malgorzata Cognome: Kielbasa Email: send email Telefono: +44 2031083033 Fax: +44 20 78132849	UK (LONDON)	participant	537˙974.00
6	EBERHARD KARLS UNIVERSITAET TUEBINGEN  Organization address address: GESCHWISTER-SCHOLL-PLATZ city: TUEBINGEN postcode: 72074 contact info Titolo: Mr. Nome: Sebastien Cognome: Claus Email: send email Telefono: +49 7071 29 77978 Fax: +49 7071 29 5784	DE (TUEBINGEN)	participant	508˙000.00
7	INSERM - TRANSFERT SA  Organization address address: Rue Watt 7 city: PARIS postcode: 75013 contact info Titolo: Dr. Nome: Jerome Cognome: Weinbach Email: send email Telefono: +33 155030139 Fax: +33 155030160	FR (PARIS)	participant	409˙831.00
8	KING'S COLLEGE LONDON  Organization address address: Strand city: LONDON postcode: WC2R 2LS contact info Titolo: Mr. Nome: Paul Cognome: Labbett Email: send email Telefono: 442078000000 Fax: 442078000000	UK (LONDON)	participant	265˙058.00
9	THALES NEDERLAND BV  Organization address address: Zuidelijke Havenweg, 40 city: HENGELO OV postcode: 7550GD contact info Titolo: Dr. Nome: Edward Cognome: Faber Email: send email Telefono: +31 53 711 2465	NL (HENGELO OV)	participant	69˙099.00
10	UNIVERSITEIT TWENTE  Organization address address: DRIENERLOLAAN 5 city: ENSCHEDE postcode: 7522 NB contact info Titolo: Ms. Nome: Jacoba Cognome: Van-Houten-Vos Email: send email Telefono: 31534892444 Fax: 31534892621	NL (ENSCHEDE)	participant	55˙458.00

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Our proposal is based on the idea that real-time functional neuroimaging can be used to train patients to regulate their own brain activity via neurofeedback training and thus modulate the brain networks of mental disorder, restore function, improve symptoms and promote resilience. We have brought together the core groups that have been instrumental in the development of methods for real-time functional imaging and fMRI (functional magnetic resonance)-based neurofeedback and have led the initial clinical applications in neuropsychiatric disorders. Our proposal has three main components, the development and refinement of methods for the real-time analysis and feedback of fMRI data and combination with other imaging modalities (WP2), the adaptation of fMRI mapping techniques to localise disease-relevant networks and development of protocols for their self-regulation through neurofeedback (WP3) and the assessment of feasibility and clinical effects in several mental disorders that are characterised by dysfunctional brain systems for motivation, emotion regulation and social communication and by important therapeutic gaps (autism spectrum disorders, alcohol addiction, post-traumatic stress disorder, childhood anxiety disorders, binge-eating disorder) (WP4). We will also explore the potential transfer of (laboratory-based) imaging feedback training into everyday settings through ambulatory and assistive technologies such as electroencephalography (EEG) and gaming (WP5). We will engage with potential users of these technologies (healthcare professionals and providers, medical instrument and software manufacturers, patient and carer associations) through several workshops, liaise with regulatory authorities and disseminate findings to the academic and user communities in WP6.'